401 related articles for article (PubMed ID: 33628181)
1. Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research.
Fisher AS; Lanigan MT; Upton N; Lione LA
Front Pharmacol; 2020; 11():614990. PubMed ID: 33628181
[TBL] [Abstract][Full Text] [Related]
2. A back translation of pregabalin and carbamazepine against evoked and non-evoked endpoints in the rat spared nerve injury model of neuropathic pain.
Lau W; Dykstra C; Thevarkunnel S; Silenieks LB; de Lannoy IA; Lee DK; Higgins GA
Neuropharmacology; 2013 Oct; 73():204-15. PubMed ID: 23747575
[TBL] [Abstract][Full Text] [Related]
3. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
Taneja A; Della Pasqua O; Danhof M
Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
[TBL] [Abstract][Full Text] [Related]
4. Improving neuropathic pain treatment - by rigorous stratification from bench to bedside.
Soliman N; Kersebaum D; Lawn T; Sachau J; Sendel M; Vollert J
J Neurochem; 2023 Feb; ():. PubMed ID: 36852505
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
Papanas N; Ziegler D
Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory and Neuropathic Pain From Bench to Bedside: What Went Wrong?
Yezierski RP; Hansson P
J Pain; 2018 Jun; 19(6):571-588. PubMed ID: 29307749
[TBL] [Abstract][Full Text] [Related]
7. Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans.
Arendt-Nielsen L; Klitgaard H; Hansen SN
Scand J Pain; 2024 Jan; 24(1):. PubMed ID: 38070164
[TBL] [Abstract][Full Text] [Related]
8. Standard analgesics reverse burrowing deficits in a rat CCI model of neuropathic pain, but not in models of type 1 and type 2 diabetes-induced neuropathic pain.
Rutten K; Gould SA; Bryden L; Doods H; Christoph T; Pekcec A
Behav Brain Res; 2018 Sep; 350():129-138. PubMed ID: 29738803
[TBL] [Abstract][Full Text] [Related]
9. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.
Percie du Sert N; Rice AS
Br J Pharmacol; 2014 Jun; 171(12):2951-63. PubMed ID: 24527763
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.
Anand P; Shenoy R; Palmer JE; Baines AJ; Lai RY; Robertson J; Bird N; Ostenfeld T; Chizh BA
Eur J Pain; 2011 Nov; 15(10):1040-8. PubMed ID: 21576029
[TBL] [Abstract][Full Text] [Related]
12. Translation of drug effects from experimental models of neuropathic pain and analgesia to humans.
Taneja A; Di Iorio VL; Danhof M; Della Pasqua O
Drug Discov Today; 2012 Aug; 17(15-16):837-49. PubMed ID: 22445930
[TBL] [Abstract][Full Text] [Related]
13. Core Outcome Measures in Preclinical Assessment of Candidate Analgesics.
Negus SS
Pharmacol Rev; 2019 Apr; 71(2):225-266. PubMed ID: 30898855
[TBL] [Abstract][Full Text] [Related]
14. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
15. Effects of alkaloids on peripheral neuropathic pain: a review.
Zhu C; Liu N; Tian M; Ma L; Yang J; Lan X; Ma H; Niu J; Yu J
Chin Med; 2020; 15():106. PubMed ID: 33024448
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic Pain: Mechanism-Based Therapeutics.
Bannister K; Sachau J; Baron R; Dickenson AH
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():257-274. PubMed ID: 31914896
[TBL] [Abstract][Full Text] [Related]
17. Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
Le Cudennec C; Castagné V
Eur J Pharmacol; 2014 Jul; 735():17-25. PubMed ID: 24726848
[TBL] [Abstract][Full Text] [Related]
18. Translational issues in precision medicine in neuropathic pain.
Dickenson AH; Patel R
Can J Pain; 2020; 4(1):30-38. PubMed ID: 32258972
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.
Kerckhove N; Mallet C; Pereira B; Chenaf C; Duale C; Dubray C; Eschalier A
BMJ Open; 2016 Dec; 6(12):e013530. PubMed ID: 27986742
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Burrowing and Stimuli-Evoked Pain Behaviors as End-Points in Rat Models of Inflammatory Pain and Peripheral Neuropathic Pain.
Muralidharan A; Kuo A; Jacob M; Lourdesamy JS; Carvalho LM; Nicholson JR; Corradini L; Smith MT
Front Behav Neurosci; 2016; 10():88. PubMed ID: 27242458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
